Who are the initiators?
EUROoCS was initiated by the ORCHID (Organ-on-Chip in Development) European
consortium of seven academic partners with the aim of:
Creating a roadmap for OoC technology.
Building a network of academia, research institutes, industry and regulatory bodies.
Raising awareness and building an ecosystem for OoC technologies.
The First EUROoCS Board:
- Christine Mummery (chair; Leiden University Medical Center, the Netherlands)
- Peter Loskill (vice-chair; Fraunhofer IGB Stuttgart/University of Tübingen, Germany)
- Janny van den Eijnden-van Raaij (secretary/treasurer; hDMT, the Netherlands)
- Albert van den Berg (member; University of Twente, the Netherlands)
EUROoCS Board as of July 3rd 2021
Full Professor for Organ-on-Chip Research at the Eberhard Karls University Tübingen
Andries van der Meer
Associate Professor at the Faculty of Science and Technology of the University of Twente
Janny van den Eijnden-van Raaij
Managing director of hDMT, the Netherlands Organ-on-Chip Consortium
Associate Professor at the Institute of Analytical Chemistry and Food Chemistry at the Graz University of Technology
EUROoCS Industrial Advisory Board as of February 1st 2023
General Manager, Global Scientific and Regulatory Affairs, San-Ei Gen F.F.I., Inc.
Director MPS in Clinical Pharmacology and Safety Sciences at AstraZeneca
EUROoCS Regulatory Advisory Board as of July 3rd 2021
Senior Advisor for Toxicology at the US Food and Drug Administration Foods Program
Unit head at the German Federal Institute for Drugs and Medical Devices (BfArM), Senior Expert in Toxicology and Regulatory Affairs
Coordinator of the Unit of non-clinical evaluators at the Belgian Federal Agency for Medicines and Health Products (FAMHP)